Fierce Biotech flags five cities poised to become next biotech powerhouses

Fierce Biotech’s latest special report identifies five cities that could emerge as major biotech hubs. The podcast episode of “The Top Line” highlights Boston, San Francisco, Beijing, Seattle and Chicago as locations with growing research and development activity.

The hosts discuss how each city’s ecosystem, talent pool and investment climate may position it to rival traditional centers. They note that US regulatory scrutiny of Chinese clinical trials is adding complexity for Beijing‑based companies.

British biotech venture capital appears to be recovering, though an IPO surge has not yet followed. The conversation also touches on Basel’s quiet rise as a Swiss biotech hub.

Listeners are invited to explore the full list and related topics in the episode’s links.